These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11330413

  • 1. Gastrointestinal damage induced by celecoxib and rofecoxib in rats.
    Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Maglione C, Aramberry L, Sambrano J, Godoy A, Rocaspana A.
    Dig Dis Sci; 2001 Apr; 46(4):779-84. PubMed ID: 11330413
    [Abstract] [Full Text] [Related]

  • 2. [Gastrointestinal damage induced by celecoxib and rofecoxib in rats].
    Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Maglione C, Aramberry LJ, Sambrano JS, Godoy A, Rocaspana A.
    Acta Gastroenterol Latinoam; 2000 Apr; 30(1):27-33. PubMed ID: 10855352
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S, Ogawa Y, Kanatsu K, Okayama M, Watanabe T, Arakawa T, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [Abstract] [Full Text] [Related]

  • 5. Effect of nimesulide, rofecoxib and celecoxib on gastric tissue glutathione level in rats with indomethacin-induced gastric ulcerations.
    Altinkaynak K, Süleyman H, Akçay F.
    Pol J Pharmacol; 2003 Nov; 55(4):645-8. PubMed ID: 14581725
    [Abstract] [Full Text] [Related]

  • 6. Both selective COX-1 and COX-2 inhibitors aggravate gastric damage induced in rats by 2-deoxy-D-glucose. relation to gastric hypermotility and COX-2 expression.
    Takeuchi K, Miyazawa T, Matsumoto M, Hayashi Y.
    Digestion; 2003 Nov; 68(2-3):71-9. PubMed ID: 14581763
    [Abstract] [Full Text] [Related]

  • 7. Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis.
    Kitahara M, Eitner F, Ostendorf T, Kunter U, Janssen U, Westenfeld R, Matsui K, Kerjaschki D, Floege J.
    J Am Soc Nephrol; 2002 May; 13(5):1261-1270. PubMed ID: 11961014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A, Taniguchi M, Takahira Y, Tanaka A, Takeuchi K.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [Abstract] [Full Text] [Related]

  • 10. Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.
    Berenguer B, Alarcón De La Lastra C, Motilva V, La Casa C, Herrerias JM, Pozo D, Calero MJ.
    Dig Dis Sci; 2004 Jun; 49(6):937-47. PubMed ID: 15309881
    [Abstract] [Full Text] [Related]

  • 11. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice.
    Hegazi RA, Mady HH, Melhem MF, Sepulveda AR, Mohi M, Kandil HM.
    Inflamm Bowel Dis; 2003 Jul; 9(4):230-6. PubMed ID: 12902846
    [Abstract] [Full Text] [Related]

  • 13. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, Ptak A, Hahn EG.
    Microsc Res Tech; 2001 Jun 01; 53(5):343-53. PubMed ID: 11376495
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M, Camici G, Fratton A, Hurlimann D, Tanner FC, Hellermann JP, Fiedler M, Thiery J, Neidhart M, Gay RE, Gay S, Lüscher TF, Ruschitzka F.
    Circulation; 2003 Nov 11; 108(19):2308-11. PubMed ID: 14597594
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.
    Tibble JA, Sigthorsson G, Foster R, Bjarnason I.
    Scand J Gastroenterol; 2000 Aug 11; 35(8):802-7. PubMed ID: 10994617
    [Abstract] [Full Text] [Related]

  • 16. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H, Amouri A, Cheikh I, Kchaou M, Ouerghi H, Ben Mami N, Ben Ammar A.
    Tunis Med; 2002 Aug 11; 80(8):427-33. PubMed ID: 12703120
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa.
    Takeuchi K, Tanaka A, Kato S, Aihara E, Amagase K.
    J Pharmacol Exp Ther; 2007 Sep 11; 322(3):903-12. PubMed ID: 17578900
    [Abstract] [Full Text] [Related]

  • 19. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov 11; 38(11):81-6. PubMed ID: 11138599
    [Abstract] [Full Text] [Related]

  • 20. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
    Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J.
    Circulation; 2004 May 04; 109(17):2068-73. PubMed ID: 15096449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.